chevron_leftBack
As of 14 June 2026, Guizhou Sanli Pharmaceutical Co.,Ltd has a market cap of $671.98M USD, ranking #13181 globally and #3975 in China.
It ranks #1192 in the Healthcare sector, and #441 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$671.98MUSD
4.55B CNY
Enterprise Value
$731.79MUSD
4.95B CNY
Revenue (TTM)
$247.34MUSD
1.68B CNY
EBITDA (TTM)
$41.38MUSD
280.04M CNY
Net Income (TTM)
$7.19MUSD
48.72M CNY
EBITDA Margin
17%
Profit Margin
2.9%
PE Ratio
96.2
PS Ratio
2.7
PB Ratio
2.9
EV/EBITDA
17.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Qianfan Zhang
open_in_new
Employees
2,852
Founded
1995
Website
gz-sanli.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.6% | 3.6% | 1.9% | -6.4% | -6.6% | -5.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
603439
贵州三力制药股份有限公司 Class A
ISIN: CNE1000040B4
Shares Out.:
Shares Outstanding:
401.061M1
Shares Float:
156.941M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.25 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Guizhou Sanli Pharmaceutical Co.,Ltd
Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonic, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. The company was founded in 1995 and is based in Anshun, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
8K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
3K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
113K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
81K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
54K%
|
97.4
|
|
SIX: RO
|
$321.52B
48K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
43K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
41K%
218.9B CHF
|
20.5
|
chevron_leftBack